HomeCompareESRCF vs JNJ

ESRCF vs JNJ: Dividend Comparison 2026

ESRCF yields 1.99% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ESRCF wins by $91.0K in total portfolio value
10 years
ESRCF
ESRCF
● Live price
1.99%
Share price
$1.51
Annual div
$0.03
5Y div CAGR
50.5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$111.1K
Annual income
$41,739.49
Full ESRCF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — ESRCF vs JNJ

📍 ESRCF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodESRCFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ESRCF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ESRCF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ESRCF
Annual income on $10K today (after 15% tax)
$168.87/yr
After 10yr DRIP, annual income (after tax)
$35,478.57/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, ESRCF beats the other by $34,774.95/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ESRCF + JNJ for your $10,000?

ESRCF: 50%JNJ: 50%
100% JNJ50/50100% ESRCF
Portfolio after 10yr
$65.5K
Annual income
$21,283.64/yr
Blended yield
32.47%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

ESRCF
No analyst data
Altman Z
0.9
Piotroski
3/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ESRCF buys
0
JNJ buys
0
No recent congressional trades found for ESRCF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricESRCFJNJ
Forward yield1.99%3.36%
Annual dividend / share$0.03$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR50.5%5.8%
Portfolio after 10y$111.1K$20.0K
Annual income after 10y$41,739.49$827.78
Total dividends collected$84.1K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: ESRCF vs JNJ ($10,000, DRIP)

YearESRCF PortfolioESRCF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,999$299.01$10,676$355.77+$323.00ESRCF
2$12,232$462.58$11,407$389.39+$825.00ESRCF
3$13,811$723.55$12,198$426.53+$1.6KESRCF
4$15,927$1,149.14$13,056$467.62+$2.9KESRCF
5$18,906$1,863.94$13,987$513.12+$4.9KESRCF
6$23,341$3,112.04$14,998$563.56+$8.3KESRCF
7$30,380$5,404.13$16,098$619.52+$14.3KESRCF
8$42,399$9,893.07$17,295$681.69+$25.1KESRCF
9$64,788$19,420.48$18,599$750.82+$46.2KESRCF
10$111,062$41,739.49$20,022$827.78+$91.0KESRCF

ESRCF vs JNJ: Complete Analysis 2026

ESRCFStock

ESR Group Limited, together with its subsidiaries, engages in the logistics real estate development, leasing, and management activities in the Public's Republic of China, Japan, South Korea, Singapore, Australia, and India. It operates through three segments: Investment, Fund Management, and Development. The company develops, constructs, invests in, and sells logistics real estate properties, as well as data centers and commercial assets. It is also involved in the fund management business; and warehousing business. In addition, the company invests in properties, co-investments funds and investment vehicles, public REITs, and other investments. It serves e-commerce companies, 3PL providers, bricks-and-mortar retailers, manufacturers, cold-chain logistics providers, and other enterprises in various industries. The company was formerly known as ESR Cayman Limited and changed its name to ESR Group Limited in June 2022. ESR Group Limited was incorporated in 2011 and is headquartered in Central, Hong Kong.

Full ESRCF Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this ESRCF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ESRCF vs SCHDESRCF vs JEPIESRCF vs OESRCF vs KOESRCF vs MAINESRCF vs ABBVESRCF vs MRKESRCF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.